🇺🇸 GKOS — Glaukos Corporation

Salud Compra fuerte
← Volver

Precio actual

246,70 USD

Máx. histórico

246,70

0 días

Caída desde máximo

En máximo

Rango 52 semanas

80,91 – 255,19

Variación hoy

+5,86%

Cierre anterior

233,04

Rango de hoy

235,95 – 255,19

Volumen hoy

2.074.592

Peor caída histórica

-69,57%

01/08/2019 → 20/03/2020

Recuperado en 299 días

Volatilidad anualizada ⓘ

54,28%

Información
Nombre completo
Glaukos Corporation
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Medical Devices
Empleados
1.094
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
242,46 USD (puede no estar actualizado)
Primera cotización
25/06/2015
Precio actualizado
hace 4 horas
Sobre la empresa

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retinal diseases in the United States and internationally. It offers iStent and iStent inject W micro-bypass stents designed to treat mild-to-moderate open-angle glaucoma through the restoration of the natural physiologic outflow pathways for aqueous humor. The company also provides iStent infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. In addition, the company develops iLink, a device used for the treatment of keratoconus without the removal of the epithelium; ILution, a platform of cream-based drug formulation applied to the outer surface of the eyelid for drop less transdermal delivery of pharmaceutically active compounds for the treatment of anterior segment eye disorders; and retinal XR platform to treat age-related macular degeneration, diabetic macular edema, retinal vein occlusion, and other posterior segment retinal diseases. It sells its products to ambulatory surgery centers, hospitals, and physician private practices through a direct sales organization, direct sales subsidiaries, and distributors. The company was formerly known as Transdx, Inc. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
20/04/2022 61,33 61,85 59,96 61,26 +0,44% 3,07% 233.000
19/04/2022 59,35 62,58 59,35 60,99 +2,92% 5,44% 353.700
18/04/2022 61,49 61,82 58,69 59,26 -2,82% 5,09% 302.500
14/04/2022 61,86 61,86 59,73 60,98 -0,47% 3,45% 403.200
13/04/2022 60,60 62,08 60,39 61,27 +1,12% 2,79% 292.700
12/04/2022 62,78 63,20 60,57 60,59 -2,56% 4,19% 513.700
11/04/2022 63,21 64,32 61,95 62,18 -2,49% 3,75% 702.100
08/04/2022 60,94 64,49 60,94 63,77 +3,29% 5,83% 912.700
07/04/2022 60,41 62,51 60,41 61,74 +2,10% 3,48% 510.200
06/04/2022 60,33 60,95 59,36 60,47 -1,47% 2,64% 640.500
05/04/2022 62,22 62,67 59,34 61,37 -0,86% 5,35% 532.100
04/04/2022 60,73 62,06 59,47 61,90 +1,84% 4,27% 463.200
01/04/2022 58,00 60,84 57,50 60,78 +5,12% 5,76% 573.800
31/03/2022 57,00 59,68 57,00 57,82 +0,89% 4,70% 469.500
30/03/2022 57,85 58,46 56,94 57,31 -0,76% 2,63% 235.300
29/03/2022 57,35 58,14 56,65 57,75 +2,28% 2,60% 274.700
28/03/2022 56,63 58,47 55,66 56,46 -0,28% 4,96% 266.200
25/03/2022 55,52 57,20 54,98 56,62 +2,61% 4,00% 279.900
24/03/2022 55,46 55,46 53,66 55,18 +0,22% 3,25% 189.600
23/03/2022 56,00 56,24 54,09 55,06 -2,24% 3,84% 204.000
22/03/2022 54,67 56,91 54,67 56,32 +2,44% 4,10% 226.100
21/03/2022 55,21 56,00 54,32 54,98 -1,10% 3,05% 169.600
18/03/2022 55,54 56,97 55,12 55,59 +0,23% 3,33% 549.600
17/03/2022 52,92 55,74 52,92 55,46 +3,80% 5,33% 202.100
16/03/2022 50,17 53,58 50,08 53,43 +7,98% 6,98% 458.800
15/03/2022 48,90 49,97 48,33 49,48 +1,83% 3,35% 330.400
14/03/2022 50,40 51,73 47,92 48,59 -4,09% 7,56% 414.400
11/03/2022 54,50 54,65 50,41 50,66 -6,69% 7,78% 295.000
10/03/2022 52,77 54,38 52,03 54,29 +0,84% 4,45% 260.000
09/03/2022 53,93 55,44 53,35 53,84 +1,41% 3,87% 368.500